Allogene Therapeutics Inc (ALLO)
SBC to Revenue
268.10%
Quarterly · Period ending:
ALLO SBC to Revenue
Latest reported268.10%period ending
Latest reported268.10%period ending
ALLO Quarterly SBC/Revenue (0.00% → 268.10%)
Latest values, visible window
High-resolution chart · PNG
ALLO sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 268.1034% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 54,200% | |
| -34,620.4545% | |
| 69,790.9091% | |
| 75,427.2727% | |
| 62,566.6667% | |
| 36,693.617% | |
| 43,159.1837% | |
| 26,617.4419% | |
| 36,581.9672% | |
| 43,207.8431% | |
| 42,563.2653% | |
| 48,031.8182% | |
| 43.7919% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |